Wedbush Maintains Outperform on Pharvaris, Raises Price Target to $42

Benzinga Newsdesk www.benzinga.com Positive 88.5%

Neg 0% Neu 0% Pos 88.5%

Wedbush analyst Laura Chico maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $41 to $42.